Home688319 • SHA
add
Chengdu Olymvax Biopharmaceuticals Inc
Previous close
ÂĄ10.84
Day range
ÂĄ10.90 - ÂĄ11.07
Year range
ÂĄ7.06 - ÂĄ22.88
Market cap
4.38B CNY
Avg Volume
2.39M
P/E ratio
-
Dividend yield
0.35%
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 155.48M | -6.52% |
Operating expense | 149.64M | 3.76% |
Net income | -1.95M | -107.90% |
Net profit margin | -1.25 | -108.42% |
Earnings per share | — | — |
EBITDA | 11.15M | -46.82% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 295.75M | -9.36% |
Total assets | 1.66B | 12.28% |
Total liabilities | 771.62M | 38.11% |
Total equity | 892.52M | — |
Shares outstanding | 406.16M | — |
Price to book | 5.00 | — |
Return on assets | 0.66% | — |
Return on capital | 0.87% | — |
Cash Flow
Net change in cash
(CNY) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.95M | -107.90% |
Cash from operations | 7.56M | -38.54% |
Cash from investing | -101.20M | -13.96% |
Cash from financing | 36.06M | -27.73% |
Net change in cash | -57.58M | -116.46% |
Free cash flow | -55.24M | -25.43% |
About
Founded
Dec 11, 2009
Website
Employees
468